Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc., trading under the ticker BLUW, is a healthcare and pharmaceutical-sector entity that filed an 8-K with the Securities and Exchange Commission on June 9, 2022, bearing accession number 0001193125-22-171016. The company operates within the therapeutics space and is associated with the SPAC vehicle Blue Water Acquisition Corp, a blank-check company that targeted opportunities in the life sciences and healthcare sectors. The June 2022 8-K represents a material disclosure filing consistent with the de-SPAC lifecycle. For complete filing details, sponsor information, transaction timelines, and ongoing status updates on BLUW and hundreds of other SPAC vehicles, sign up for full data access at SpacDesk.